A randomized, therapy controlled, double blind, single center cross-over pilot study to evaluate the antihypertensive and pleiotropic effects of telmisartan in comparison to amlodipin on myocardial diastolic function , vascular function and carbohydrate metabolism in 30 patients with metabolic syndrome, mild to moderate hypertension and without overt coronary artery disease

Trial Profile

A randomized, therapy controlled, double blind, single center cross-over pilot study to evaluate the antihypertensive and pleiotropic effects of telmisartan in comparison to amlodipin on myocardial diastolic function , vascular function and carbohydrate metabolism in 30 patients with metabolic syndrome, mild to moderate hypertension and without overt coronary artery disease

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 10 Jun 2011

At a glance

  • Drugs Telmisartan (Primary) ; Amlodipine
  • Indications Heart failure; Hypertension
  • Focus Pharmacodynamics
  • Acronyms telmipleio
  • Most Recent Events

    • 10 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top